Stock listing
Seaport Therapeutics, Inc.
Selected listing: SPTX · NASDAQ · USD · US
Seaport Therapeutics, Inc. (NASDAQ:SPTX), Health Technology. Latest release Sep 14, 2026: Seaport Therapeutics to Participate in September Investor Conferences.
- Ticker
- NASDAQ:SPTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. (SPTX) is a public company based in the United States, focusing on innovative therapeutic solutions. The company is committed to developing its portfolio to address unmet medical needs.
Latest news from Seaport Therapeutics, Inc.
Seaport Therapeutics to Participate in September Investor Conferences
September 14, 2026
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 9, 2026
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 3, 2026
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 7, 2026
Research Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. company profile
View the public company page for Seaport Therapeutics, Inc. on 6ix.
Seaport Therapeutics, Inc. news
Read company news and market updates connected to Seaport Therapeutics, Inc..
Seaport Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Seaport Therapeutics, Inc..